Affirm Holdings, Inc. (AFRM)

Marinus Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Operating Revenue	1,480	1,119	902.77	821.41	544.05	322.8
Other Revenue	1,527	1,204	685.22	527.88	326.42	186.73
Revenue	3,007	2,323	1,588	1,349	870.46	509.53
Revenue Growth (YoY)	42.55%	46.29%	17.69%	55.01%	70.84%	92.73%
Cost of Revenue	1,641	1,329	912.48	686.86	438.86	348.67
Gross Profit	1,366	994.47	675.5	662.43	431.61	160.86
Selling, General & Admin	1,024	1,100	1,222	1,110	554.4	146.27
Research & Development	559.35	501.86	615.82	418.64	249.34	122.38
Operating Expenses	1,583	1,602	1,837	1,528	803.73	268.65
Operating Income	-216.59	-607.33	-1,162	-866.05	-372.12	-107.79
Interest Expense	-5.24	-3.4	-3.9	-2.4	-	-
Other Non Operating Income (Expenses)	80.48	105.18	125.68	143.62	-59.7	-4.43
EBT Excluding Unusual Items	-141.34	-505.55	-1,040	-724.83	-431.83	-112.22
Merger & Restructuring Charges	0.34	-6.77	-37.67	-	-	-
Impairment of Goodwill	-1	-1	-	-	-	-
Gain (Loss) on Sale of Investments	-0.4	-14.1	-	-	-	-
Asset Writedown	-1.55	-0.75	-1.24	-	-11.54	-
Other Unusual Items	89.7	12.64	89.84	-	-	-
Pretax Income	-54.26	-515.53	-989.25	-724.83	-443.37	-112.22
Income Tax Expense	7.94	2.23	-3.9	-17.41	-2.34	0.38
Net Income	-62.19	-517.76	-985.35	-707.42	-441.03	-112.6
Net Income to Common	-62.19	-517.76	-985.35	-707.42	-441.03	-112.6
Shares Outstanding (Basic)	320	310	295	282	158	48
Shares Outstanding (Diluted)	320	310	295	282	159	48
Shares Change (YoY)	4.60%	4.91%	4.84%	76.90%	232.75%	1.08%
EPS (Basic)	-0.19	-1.67	-3.34	-2.51	-2.78	-2.35
EPS (Diluted)	-0.19	-1.67	-3.34	-2.51	-2.94	-2.63
Free Cash Flow	608.71	290.84	-108.59	-248.48	-213.38	-92.32
Free Cash Flow Per Share	1.90	0.94	-0.37	-0.88	-1.34	-1.93
Gross Margin	45.44%	42.81%	42.54%	49.09%	49.58%	31.57%
Operating Margin	-7.20%	-26.14%	-73.17%	-64.19%	-42.75%	-21.15%
Profit Margin	-2.07%	-22.29%	-62.05%	-52.43%	-50.67%	-22.10%
Free Cash Flow Margin	20.24%	12.52%	-6.84%	-18.42%	-24.51%	-18.12%
EBITDA	63.41	-365.21	-941.79	-716.59	-283.04	-98.35
EBITDA Margin	2.11%	-15.72%	-59.31%	-53.11%	-32.52%	-19.30%
D&A For EBITDA	280	242.11	220.16	149.46	89.08	9.44
EBIT	-216.59	-607.33	-1,162	-866.05	-372.12	-107.79
EBIT Margin	-7.20%	-26.14%	-73.17%	-64.19%	-42.75%	-21.15%
Revenue as Reported	3,007	2,323	1,588	1,349	870.46	509.53
Advertising Expenses	-	19.2	22.6	74	48.1	3.3

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q